Research
Energy balance
Endoscopic sleeve gastroplasty (ESG) is safe and effective in patients with a BMI of 27-30, with a mean total weight loss of 11.0% at 6 months and 15.5% at 12 months.
Practitioners can consider ESG as a viable option for overweight patients seeking weight loss.
StrongSupportsmedium confidence
ESG seems to be well tolerated, safe, and effective in patients with a BMI of 27-30.
Why this rating
Based on a prospective cohort analysis of a significant number of procedures.
Source
Endoscopic Sleeve Gastroplasty in Those With a Body Mass Index of 27–30
Aayed Alqahtani et al. · The American Journal of Gastroenterology · 2023
cohort · n=656Cited 7×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →